EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inverse Association of p63 Expression with Hormone Receptor Status in Invasive Breast Cancer

Panagis Lykoudis, Maria Papadoliopoulou, Alexios Kozonis iD, Georgios Kirkilesis iD, Marios-Konstantinos Tasoulis iD, Mahrokh Nohadani, Mihir A Gudi

Journal of Personalized Medicine · 01.07.2026 · 16 (7) · 359

DOI: 10.3390/jpm16070359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 01.07.2026. Verfasst von Panagis Lykoudis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Imperial College London, London SW2 1NY, UK. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Immunohistochemistry is an integral component of the diagnostic approach in breast cancer and remains essential for tumor characterization and therapeutic decision-making. p63 gene expression may have potential diagnostic and prognostic roles in breast cancer patients.

Methods

In this study, 127 specimens of invasive breast carcinoma and 50 control cases were evaluated for p63 gene expression and compared to other pathology factors.

Results

None of the 50 control cases was assessed as positive for p63 expression. Progesterone and estrogen receptor status were the only factors that demonstrated a statistically significant negative correlation with p63 expression (p = 0.005 and p = 0.017, respectively). Tumor size demonstrated a marginally non-significant correlation with p63 expression (p = 0.051). None of the remaining factors was significantly correlated with p63 expression.

Conclusions

In conclusion, p63 expression is inversely correlated with estrogen and progesterone receptor status, and type, size and grade of the tumors are not correlated with the gene’s expression, nor is HER2 status. This conclusion might impact genotype-based stratification pertinent to diagnosis and tailored treatment.

Schlagwörter

Stichwörter der Autor:innen

breast cancerluminal typep63 gene expression

Autor:innen und Institutionen

  • Department of Pathology, Imperial College London, London SW2 1NY, UK.
  • Attikon University Hospital, National and Kapodistrian University of Athens, Rimini 1, 12462 Chaidari, Greece.
  • Breast Surgery Unit, The Royal Marden NHS Foundation Trust, London SW3 6JJ, UK.
  • Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK.
  • Hammersmith Hospital, Imperial College London, London SW7 2BX, UK.
  • Department of Pathology and Laboratory Medicine, KK Women's and Children Hospital, 100 Bukit Timah Road, Singapore 229899, Singapore.

ORCID-Profile: Alexios Kozonis, Georgios Kirkilesis, Marios-Konstantinos Tasoulis

Zitieren

APA

Lykoudis, P., Papadoliopoulou, M., Kozonis, A., Kirkilesis, G., Tasoulis, M. K., Nohadani, M., & Gudi, M. A. (2026). Inverse Association of p63 Expression with Hormone Receptor Status in Invasive Breast Cancer. Journal of Personalized Medicine, 16(7), 359. https://doi.org/10.3390/jpm16070359

Vancouver

Lykoudis P, Papadoliopoulou M, Kozonis A, Kirkilesis G, Tasoulis MK, Nohadani M, et al. Inverse Association of p63 Expression with Hormone Receptor Status in Invasive Breast Cancer. Journal of Personalized Medicine. 2026;16(7):359. doi:10.3390/jpm16070359

BibTeX
@article{Lykoudis2026,
  author = {Lykoudis, Panagis and Papadoliopoulou, Maria and Kozonis, Alexios and Kirkilesis, Georgios and Tasoulis, Marios-Konstantinos and Nohadani, Mahrokh and Gudi, Mihir A},
  title = {Inverse Association of p63 Expression with Hormone Receptor Status in Invasive Breast Cancer},
  journal = {Journal of Personalized Medicine},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {359},
  doi = {10.3390/jpm16070359}
}
Kostenlos starten →